COMMUNIQUÉS West-GlobeNewswire

TimelyCare Unveils "Connected Care for Every Student," with an AI Well-being Guide as an Easier First Step
17/09/2026
Built for every student, including those who would never book an appointment, the model pairs an AI well-being guide with human coaching and licensed clinical care. Fort Worth, TX, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
17/09/2026
Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases Marea has multiple late-stage clinical product candidates: MAR001/005 for severe hypertriglyceridemia (sHTG) [...]
LQpay Introduces Custom AI Assistant LuQ, Bringing AI Directly into the Healthcare Payments Experience
17/09/2026
LuQ marks the first step in LQpay’s broader strategy to leverage AI and emerging technologies to simplify workflows, enhance automation and help healthcare organizations work more efficiently PLANTATION, Fla., Sept. 17 [...]
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
17/09/2026
COPENHAGEN, Denmark, Sept. 17, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced that the first patient has been enrolled in Part 2 of the Phase 1b/2a clinical trial of SNIPR001 (NCT06938867), the Company's lead CRISPR- [...]
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
17/09/2026
Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH
17/09/2026
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH The 2026 Award, open to early career investigators from around the world, was dedicated to advancing research in [...]
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
17/09/2026
Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Two Herbalists Spent Six Years Formulating an Energy Bar. Here's Why It Took That Long.
17/09/2026
ILA launches Chocolate and Peanut adaptogenic energy bars, the first products from a formulation process co-founders Amy Saleh and Eileen Brantley refused to rush ATLANTA, GA , Sept. 17, 2026 (GLOBE NEWSWIRE) -- Most [...]
Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study
17/09/2026
Phase III CELESTIMO study met its primary endpoint at the interim analysis demonstrating a statistically significant and clinically meaningful reduction in the risk of disease progression in people with follicular [...]
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
17/09/2026
Patient experience data (PED) are direct insights that patients provide on their symptoms, quality of life, treatment preferences and unmet needs. PED Essentials is an online learning hub, co-created with patients and [...]
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
17/09/2026
COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin [...]
Le Groupe RAMSAY SANTE dévoile "Connecting Care 2030"
17/09/2026
COMMUNIQUÉ DE PRESSE Paris, le 17 septembre 2026 Le groupe Ramsay Santé dévoile « Connecting Care 2030 », pour accélérer sa croissance rentable et créer de la valeur durable pour l’ensemble de ses parties prenantes « [...]
RAMSAY SANTE Group unveils "Connecting Care 2030"
17/09/2026
PRESS RELEASE Paris, 17 September 2026 Ramsay Santé Group unveils “Connecting Care 2030” to drive next phase of profitable growth and create long term value for all stakeholders “Connecting Care 2030”, Ramsay Santé [...]
MEDVi QUAD Formula Update Confirmed for 2026: Apomorphine Replaces PT-141 in Current 4-in-1 Combination
17/09/2026
Sildenafil, Tadalafil, Apomorphine, and L-Citrulline Confirmed as MEDVi's Current QUAD Formulation for Compounded ED Treatment Newark, DE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved [...]
Desert Hope Treatment Center Names Blaise Schafer Lead Clinician for New First Responders Program
17/09/2026
LAS VEGAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center has named Blaise Schafer, LCSW, lead clinician for its new First Responders Program at its residential treatment facility in Las Vegas. The [...]
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
16/09/2026
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of [...]
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
16/09/2026
Shareholders grant the Board discretionary authority to implement a share consolidation of up to 30:1 TORONTO and HAIFA, Israel, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/09/2026
BRISBANE, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
16/09/2026
CONSHOHOCKEN, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]

Pages